Regulation of GFAP Expression
ASN Neuro · 2021-01 · 13 (1)
DOI: 10.1177/1759091420981206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ASN Neuro, online erschienen am 18.02.2021. Verfasst von Michael Brenner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, University of Alabama-Birmingham, Birmingham, Alabama, United States. Hauptthemen laut MEDLINE: Astrocytes, Gliosis. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Expression of the GFAP gene has attracted considerable attention because its onset is a marker for astrocyte development, its upregulation is a marker for reactive gliosis, and its predominance in astrocytes provides a tool for their genetic manipulation. The literature on GFAP regulation is voluminous, as almost any perturbation of development or homeostasis in the CNS will lead to changes in its expression. In this review, we limit our discussion to mechanisms proposed to regulate GFAP synthesis through a direct interaction with its gene or mRNA. Strengths and weaknesses of the supportive experimental findings are described, and suggestions made for additional studies. This review covers 15 transcription factors, DNA and histone methylation, and microRNAs. The complexity involved in regulating the expression of this intermediate filament protein suggests that GFAP function may vary among both astrocyte subtypes and other GFAP-expressing cells, as well as during development and in response to perturbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, University of Alabama-Birmingham, Birmingham, Alabama, United States.
- Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, United States.
- Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States.
ORCID-Profile: Albee Messing
Förderung
- NICHD NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- The Palamaro Fund
- The Juanma Fund
- The Jelte Rijkaart Fund
- Children Living with Inherited Metabolic Diseases
- United Leukodystrophy Foundation
Zitieren
APA
Brenner, M., & Messing, A. (2021). Regulation of GFAP Expression. ASN Neuro, 13(1). https://doi.org/10.1177/1759091420981206
Vancouver
Brenner M, Messing A. Regulation of GFAP Expression. ASN Neuro. 2021;13(1). doi:10.1177/1759091420981206
BibTeX
@article{Brenner2021,
author = {Brenner, Michael and Messing, Albee},
title = {Regulation of GFAP Expression},
journal = {ASN Neuro},
year = {2021},
volume = {13},
number = {1},
doi = {10.1177/1759091420981206}
}
EUVIMED